Novel physiologically active substances

Details for Australian Patent Application No. 2002230128 (hide)

Owner Eisai Co., Ltd. Mercian Corporation

Inventors Sakai, Takashi; Norihisa, Koji; Tsuchida, Toshio; Yoshida, Masashi; Fujita, Masanori; Matsufuji, Motoko; Dobashi, Kazuyuki; Okuda, Akifumi; Yamamoto, Satoshi; Kotake, Yoshihiko; Kawamura, Naoto; Iwata, Masao; Komeda, Keisuke; Sameshima, Tomohiro; Niijima, Jun; Yamori, Takao; Mizui, Yoshiharu; Nakashima, Takashi; Nagai, Mitsuo; Takeda, Susumu; Okamoto, Kiyoshi; Asai, Naoki; Kishi, Kumiko; Yamada, Tomonari; Uenaka, Toshimitsu

Agent Davies Collison Cave

Pub. Number AU-B-2002230128

PCT Pub. Number WO2002/060890

Priority 2001-25458 01.02.01 JP

Filing date 1 February 2002

Wipo publication date 12 August 2002

Acceptance publication date 19 April 2007

International Classifications

C07D 313/00 (2006.01) Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 31/336 (2006.01) - having three-membered rings, e.g. oxirane, fumagillin

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61K 31/74 (2006.01) - Synthetic polymeric materials

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

C07D 493/08 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

C12P 17/02 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - Oxygen as only ring hetero atoms

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002230128

19 April 2007 Application Accepted

  Published as AU-B-2002230128

31 May 2007 Assignment before Grant

  Eisai Co., Ltd.; Mercian Corporation The application has been assigned to Mercian Corporation; Eisai R&D Management Co., Ltd.

16 August 2007 Standard Patent Sealed

8 March 2012 Assignment Registered

  Eisai R&D Management Co., Ltd.; Mercian Corporation The patent has been assigned to Eisai R&D Management Co., Ltd.; MicroBiopharm Japan Co., Ltd. Assignments Registered

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002230129-NOVEL PHYSIOLOGICALLY ACTIVE PEPTIDE AND USE THEREOF

2002230127-HYBRIDIZED ARRAY ANALYSIS AIDING METHOD AND ANALYSIS AIDING DEVICE